Stand Up To Cancer has awarded USC Norris a $550,000 Grant to Help Diverse Populations Access Cancer Clinical Trials

To reduce health disparities and advance health equity, it is crucial that people from diverse backgrounds participate in clinical trials, so researchers can better understand the risks as well as the benefits novel treatments present to different populations.

Now, a two-year grant from Stand Up To Cancer® (SU2C) will fund a new program at the USC Norris Comprehensive Cancer Center to eliminate barriers and facilitate access to early phase cancer clinical trials in traditionally underserved communities in Los Angeles County. This grant was funded as part of the SU2C Diversity in Early Development Clinical Trials Research Grants Program and is supported by a sponsorship from Janssen Pharmaceutical Companies of Johnson & Johnson. As a part of SU2C’s Health Equity Initiative, the program aims to create unique and replicable approaches that engage medically underserved communities in Phase 1 and Phase 2 cancer clinical trials. (…Read More)